- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/34 - 1,4-OxazinesHydrogenated 1,4-oxazines condensed with carbocyclic rings
Patent holdings for IPC class C07D 265/34
Total number of patents in this class: 107
10-year publication summary
|
4
|
8
|
3
|
10
|
8
|
7
|
11
|
5
|
7
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5725 |
8 |
| AbbVie Deutschland GmbH & Co. KG | 257 |
5 |
| VALO Health, Inc. | 192 |
5 |
| Oregon Health & Science University | 755 |
4 |
| Vividion Therapeutics, Inc. | 42 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2657 |
3 |
| Neumedics | 5 |
3 |
| Teijin Pharma Limited | 255 |
3 |
| Wuhan Createrna Science and Technology Co.,Ltd. | 32 |
3 |
| F. Hoffmann-La Roche AG | 7838 |
2 |
| Agency for Science, Technology and Research | 3722 |
2 |
| Fondazione Istituto Italiano di Tecnologia | 625 |
2 |
| UDC Ireland Limited | 510 |
2 |
| Xenon Pharmaceuticals Inc. | 196 |
2 |
| Certa Therapeutics Pty. Ltd. | 18 |
2 |
| Samsung Electronics Co., Ltd. | 157300 |
1 |
| Hoffmann-La Roche Inc. | 3777 |
1 |
| Samsung Display Co., Ltd. | 38544 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| FUJIFILM Corporation | 30479 |
1 |
| Other owners | 52 |